Advertisement
Organigram Global Inc.

Organigram Global Inc. (OGI) Stock Overview

Explore Organigram Global Inc.’s financial performance, market position, analyst ratings, and future outlook.

OGINASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$1.03
$0.07(7.30%)
U.S. Market opens in 54h 50m
Advertisement

Organigram Global Inc. (OGI)

Meyka AI Score

Z

Key Financials

Market Cap145M
P/E Ratio-7.75
EPS (TTM)$-0.26
ROE-0.07%
Fundamental Analysis

AI Price Forecasts

1 Month$1.05
3 Months$1.65
1 Year Target$1.31

OGI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Organigram Global Inc. (OGI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 45.38, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.31.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -7.75 and a market capitalization of 145M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
7.30%
5-Day Change
7.28%
1-Month Change
-7.21%
3-Month Change
-21.37%
6-Month Change
-42.46%
Year-to-Date (YTD) Change
-38.69%
1-Year Change
-26.43%
3-Year Change
-33.55%
5-Year Change
-91.18%
All-Time (Max) Change
-96.70%

Contact Information

15063841571
35 English Drive, Moncton, NB, E1E 3X3

Company Facts

10,930 Employees
IPO DateMay 21, 2019
CountryCA
Actively Trading

Frequently Asked Questions